Xeptiva Therapeutics
PrivateLast Round
Seed
Oct 1, 2024
Total Funding Raised
$2.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Xeptiva Therapeutics is a biotechnology company that develops therapeutic vaccines for chronic inflammatory conditions in companion animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xeptiva Therapeutics Comparables
Compare Xeptiva Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zoetis Inc. | 78% | |
| Vetbiolix | 78% | |
| Boehringer Ingelheim | 77% |
Xeptiva Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 1, 2024 |
Key People
Founding team and executive leadership
Xeptiva Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zentynel Frontier Investments | Seed |
| Fen Ventures | Seed |
| ND Latam | Seed |
| iThink VC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 117% MoM, reaching 3.1K.
- Nov 10, 2025
Developing vaccine biomarkers with Athos Therapeutics using their AI platform.
Xeptiva Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Xeptiva Therapeutics's valuation, stock price, and market status.
Is Xeptiva Therapeutics a public or private company?
Xeptiva Therapeutics is a private company.
What is the current stock price of Xeptiva Therapeutics?
Xeptiva Therapeutics is a private company, so its shares have no public market price. Caplight tracks Xeptiva Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xeptiva Therapeutics worth (valuation)?
Valuation information for Xeptiva Therapeutics is not publicly available.
Can I buy Xeptiva Therapeutics stock?
Xeptiva Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xeptiva Therapeutics's last funding round?
Xeptiva Therapeutics's most recent funding round was Seed on October 1, 2024.
Who are the main investors in Xeptiva Therapeutics?
Key investors in Xeptiva Therapeutics include Zentynel Frontier Investments.
Will Xeptiva Therapeutics IPO soon?
No public IPO plans have been announced for Xeptiva Therapeutics.
How can I track Xeptiva Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Xeptiva Therapeutics's shares on secondary markets.